Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL515391 | 0.93 | DNM1 (0.36) | ALDH1A1TSHRDNM1CES2 | |
| SCHEMBL2586062 | 0.93 | DNM1 (0.36) | ALDH1A1TSHRDNM1CES2 | |
| SCHEMBL98889 | 0.80 | CES2 (0.34) | CES2 | |
| SCHEMBL6756058 | 0.80 | CES2 (0.34) | CES2 | |
| SCHEMBL4902282 | 0.79 | CES2 (0.34) | ALDH1A1HSD17B10MEN1KMT2ATSHR | |
| SCHEMBL4611396 | 0.78 | CES2 (0.36) | ALDH1A1HSD17B10MEN1KMT2ATSHR | |
| SCHEMBL4609450 | 0.78 | CES2 (0.36) | ALDH1A1HSD17B10MEN1KMT2ATSHR | |
| SCHEMBL98645 | 0.76 | GPR84 (0.33) | CES2 | |
| SCHEMBL332249 | 0.74 | FDPS (0.39) | CES2 | |
| SCHEMBL14801394 | 0.74 | FDPS (0.39) | CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2605745-B1 | CLEAR LIQUID COMPOSITION COMPRISING ALKANOYL GLYCINATE, AMPHOTERIC SURFACTANT, ALKYL SULFATE AND SPECIFIC ASSOCIATIVE ACRYLATE POLYMERS | UNILEVER PLC (GB) | 2017-05-31 | — | — | EP | disclosed |
| US-8703687-B2 | Clear liquid composition comprising alkanoyl glycinate, amphoteric, alkyl sulfate and specific acrylate polymers | CONOPCO, INC. (US) | 2014-04-22 | — | — | US | disclosed |
| EP-2605745-A2 | CLEAR LIQUID COMPOSITION COMPRISING ALKANOYL GLYCINATE, AMPHOTERIC SURFACTANT, ALKYL SULFATE AND SPECIFIC ASSOCIATIVE ACRYLATE POLYMERS | Unilever PLC (GB) | 2013-06-26 | — | — | EP | disclosed |
| WO-2012022614-A2 | CLEAR LIQUID COMPOSITION COMPRISING ALKANOYL, GLYCINATE, AMPHOTERIC, ALKYL SULFATE AND SPECIFIC ACRYLATE POLYMERS | UNILEVER PLC (GB) | 2012-02-23 | — | — | WO | disclosed |
| US-20120046210-A1 | Clear Liquid Composition Comprising Alkanoyl Glycinate, Amphoteric, Alkyl Sulfate and Specific Acrylate Polymers | CONOPCO, INC., D/B/A UNILEVER (US) | 2012-02-23 | — | — | US | disclosed |
| EP-1871864-B1 | LOW AMOUNTS OF HIGH MOLECULAR WEIGHT POLYMERS FOR ENHANCING VISCOSITY OF AQUEOUS/AQUEOUS BIPHASIC LIQUIDS | UNILEVER PLC (GB) | 2011-02-23 | — | — | EP | disclosed |
| EP-1743625-B1 | Method for providing dilution thickening using polydextrose based biphasic compositions | UNILEVER PLC (GB) | 2009-11-25 | — | — | EP | disclosed |
| EP-1529097-B1 | BIPHASIC COMPOSITION INDUCED BY POLYDEXTROSE | UNILEVER PLC (GB) | 2009-10-14 | — | — | EP | disclosed |
| US-7473673-B2 | Hydrophilic structured bar compositions comprising individually coated flat platy particles, each having surface deposition chemistry mechanism | CONOPCO, INC. (US) | 2009-01-06 | — | — | US | disclosed |
| US-7273840-B2 | Method for providing dilution thickening using polydextrose based biphasic compositions | CONOPCO, INC. (US) | 2007-09-25 | — | — | US | disclosed |
| US-20060140897-A1 | Biphasic inducing agent for aqueous cleansing compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2006-06-29 | — | — | US | disclosed |
| US-7012049-B2 | Multiphase aqueous cleansing composition | CLARIANT FINANCE (BVI) LIMITED (VG) | 2006-03-14 | — | — | US | disclosed |
| US-20050215443-A1 | MULTIPHASE AQUEOUS CLEANSING COMPOSITION | CLARIANT INTERNATIONAL LTD. | 2005-09-29 | — | — | US | disclosed |
| EP-1580259-A1 | Multiphase aqueous cleansing composition | CLARIANT INTERNATIONAL LTD. (CH) | 2005-09-28 | — | — | EP | disclosed |
| EP-1311227-B1 | A SEPARATING MULTI-PHASE PERSONAL WASH COMPOSITION IN A TRANSPARENT OR TRANSLUCENT PACKAGE | UNILEVER PLC (GB) | 2004-09-29 | — | — | EP | disclosed |
| US-6787511-B2 | SURFACTANTS AND POLYDEXTROSE, CLEANSING COMPOUNDS | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. | 2004-09-07 | — | — | US | disclosed |
| US-6727209-B2 | USE OF SUCROSE WIDENS THE WINDOW OF POLYDEXTROSE WHICH CAN BE USED AND LOWERS THE LEVELS OF POLYDEXTROSE NECESSARY TO ACHIEVE BIPHASIC EFFECT | UNILEVER HOME & PERSONAL CARE, USA, DIVISION OF CONOPCO, INC. | 2004-04-27 | — | — | US | disclosed |
| US-20040038837-A1 | BIPHASIC COMPOSITION INDUCED BY POLYDEXTROSE AND SUCROSE | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-02-26 | — | — | US | disclosed |
| US-20040033914-A1 | Biphasic composition induced by polydextrose | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-02-19 | — | — | US | disclosed |
| US-6429177-B1 | POLYALKYLENE GLYCOL, SURFACTANT, THICKENER AND NONCHELATING MINERAL SALT; FORMS SINGLE PHASE ON AGITATION AND RETURNS TO MULTIPHASE ON STANDING; STABLE TO RECRYSTALLIZATION AND HYDROLYSIS; BODY WASH, SHOWER GEL, FOAM BATH OR SHAMPOO | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040033914-A1 | Biphasic composition induced by polydextrose | DAD1, DUSP6, DDOST | LMNA 4667/4885ALDH1A1 4126/4885HSD17B10 2353/4885 |
| US-20060140897-A1 | Biphasic inducing agent for aqueous cleansing compositions | CD14, PHOSPHO1, SELENOI | LMNA 3534/4885ALDH1A1 3399/4885HSD17B10 1861/4885 |
| US-20120046210-A1 | Clear Liquid Composition Comprising Alkanoyl Glycinate, Amphoteric, Alkyl Sulfate and Specific Acrylate Polymers | ACR, ALG1, CD44 | LMNA 833/4885ALDH1A1 3006/4885HSD17B10 974/4885 |
| US-20040038837-A1 | BIPHASIC COMPOSITION INDUCED BY POLYDEXTROSE AND SUCROSE | SLC5A2, SLC5A1, DUSP6 | LMNA 4731/4885ALDH1A1 4485/4885HSD17B10 3069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.